P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
